SCHEMBL3741368

SCHEMBL3741368

Cc1cccc(C(C)(C(=O)O)N2CCN(C)CC2)n1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR3E A5X5Y0 1/20 0.44
HTR3B O95264 1/20 0.44
HTR3A P46098 1/20 0.44
HTR3D Q70Z44 1/20 0.44
HTR3C Q8WXA8 1/20 0.44
POLB P06746 1/20 0.39
ALDH1A1 P00352 3/20 0.38
KDM4E B2RXH2 2/20 0.38
GAA P10253 2/20 0.37
HPGD P15428 1/20 0.37
TSHR P16473 1/20 0.37
CHRM3 P20309 1/20 0.36
HTR1A P08908 1/20 0.36
DRD2 P14416 1/20 0.36
DRD4 P21917 1/20 0.36
HRH4 Q9H3N8 2/20 0.35
SIGMAR1 Q99720 1/20 0.35
APOBEC3A P31941 1/20 0.35
APOBEC3G Q9HC16 1/20 0.35
HSD17B10 Q99714 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3641673 0.79 CHRM3 (0.40) POLBALDH1A1KDM4EHPGDTSHR
SCHEMBL3753022 0.77 KMT2A (0.43) POLBALDH1A1KDM4EGAAHPGD
SCHEMBL26698239 0.74 CHRM3 (0.55) POLBALDH1A1HPGDTSHRCHRM3
SCHEMBL126954 0.72 RAB9A (0.43) ALDH1A1KDM4EHPGDHSD17B10
SCHEMBL3743951 0.71 SSTR4 (0.41) GAACHRM3HRH4MAPT
SCHEMBL3737460 0.68 SSTR4 (0.42) POLBCHRM3HRH4MAPT
SCHEMBL3747921 0.66 NOS2 (0.41) ALDH1A1KDM4ECHRM3HRH4
SCHEMBL26698267 0.66 CHRM3 (0.52) POLBALDH1A1HPGDTSHRCHRM3
SCHEMBL3633189 0.65 HTR3E (0.45) HTR3EHTR3BHTR3AHTR3DHTR3C
SCHEMBL19534745 0.65 ALDH1A1 (0.46) ALDH1A1KDM4ETSHRMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100286152-A1 N-PHENYL HYDRAZIDES AS MODULATORS OF THE GHRELIN RECEPTOR GLAXO GROUP LIMITED (GB) 2010-11-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100286152-A1 N-PHENYL HYDRAZIDES AS MODULATORS OF THE GHRELIN RECEPTOR GIPR, GHSR, GLP1R HTR3E 219/4885HTR3B 210/4885HTR3A 264/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.